Big Changes to Heart Devices OK’d Without New Data

▲Click for full story

“Many of the high-risk implantable cardiac devices in use today were approved through a supplement pathway that does not require new clinical data on the safety and effectiveness of changes made to the products since their original approval, a review of an agency database showed.”

***

By Todd Neale

Advertisements